Dalal Street Investments
Top

Ranbaxy: Nephew following Uncle’s Footsteps

June 11, 2008

It seems like Malvinder Singh’s uncle, Analjit Singh has a deep influence on the former when it runs to corporate and business practices. Ranbaxy, the dream company of late Dr.Parvinder Singh is likely to be sold to Daiichi. Singh family controls 34% stake in Ranbaxy Labs.

If you recall, Analjit Singh successfully ventured into Paging business in early 90s and sold it off at the peak to Hutchison by virtue of which he got stake in Hutchison India, later Hutchison Essar. Hutchison sold their stake at peak just last year to Vodafone. Analjit Singh made a killing by patiently holding on to his stake.

It is still not clear how Malvinder will handle group company stakes in Religare and Fortis Hospitals held by Rfanbaxy Labs.

Comments

Got something to say?






Bottom